Sun Pharmaceutical Industries plans to invest $280 million in experimental … – Economic Times

Sun Pharmaceutical Industries plans to invest $280 million in experimental
Economic Times
NEW DELHI: Sun Pharmaceutical Industries Ltd., India’s largest domestic drug maker by market capitalisation, plans to invest more than $280 million in the experimental psoriasis drug that it in-licensed from US-based Merck Sharp& Dohme (MSD) last month …

Source: pharmaceutical – Google News

Sharing information is key – Pharmaceutical Business News UK. Social Commerce and Social Media Management playing a big part. Suaju Ltd